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1. Introduction 
Glutaraldehyd-fixed heart valve prostheses with long durability and function are desirable 
as a treatment option of heart valve disease. They do not require chronic anticoagulation 
therapy, however break down quickly in young patients (<5 years) but last for > 15 years in 
patients older than 70 years. It is generally accepted that the break down of bioprosthetic 
heart valves is due to calcification occurring because of immunologic and chemical 
processes.  
Thus, new nano- technological methods in combination with chemical and biochemical 
procedures concerning detoxification and titanization of glutardialdehyde- fixed collagen 
scaffolds are applied on glutardialdehyde fixed pericardial samples. Nano-  technology with 
titanium using a plasma application under high alternating current, developed elsewhere 
(GfE Nürnberg, Germany, patent number EP 0 897 997 A1) might decrease the immune 
response caused by coating and improve endothelialization by detoxification and the 
biocompatibility of titanium. A plasma-activated surface of collagen allows a titanization 
under room temperature described later on. Immune response with secondary dystrophic 
calcification may be why glutaraldehyde fixed xenograft valves fail, especially in young 
patients. Hypothesis is, detoxification and titanization may reduce immunologic reactions 
and enable an endothelialization. 
2. Detoxification and titanium coating of glutaraldehyde-fixed pericardium 
Free aldehyde-groups of glutaraldehyde-fixed pericardium are responsible for its toxicity, 
which prevents an endothelialization. 
2.1 Detoxification   
Platelets of glutaraldehyde- fixed pericardium were treated differently for detoxification. 
Some were detoxified chemically by incubation with citric acid (CA) of 10%. Others were 
detoxified enzymatically by aldehyde dehydrogenase and received nano-technological 
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methods using plasma activation either solely or combined with a treatment of organic 
bound titanium. 
2.2 Determination of free aldehyde groups 
A method for the determination of the amount of glutaraldehyde in specimens of 
glutaraldehyde fixed pericardium has been developed using aldehyde dehydrogenase 
(ALDH), (Guldner et.al. 2009). In presence of ALDH, aldehydes are oxidated to carbon 
acids while a reduction equivalent (here: NAD+) is reduced. Aldehyde dehydrogenases 
have broad substrate specificity. Thus, they process glutardialdehyde as well as other 
aldehydes 
 
 
Acetaldehyde +      NAD+    →      Acetic acid      +     NADH 
 
The determination of aldehydes with the ALDH method was performed photometrically. 
The increase of optical density (extension) by the reduced NADH could be measured at a 
wave length of 340nm. The amount of NADH being proportional to the original amount of 
aldehyde, statements on the remaining toxicity of the fixed pericardium could be made. 
Optimal duration for incubation was inquired. 
Enzyme, NAD+ (tablets) and buffer solution from a commercially available kit, originally 
developed to determine acetaldehyde concentrations in a variety of materials, were used 
(Acetaldehyde, Enzymatic BioAnalysis; R-Biopharm, Darmstadt, Germany). Platelets of 
pericardium were incubated in a 24 well plate with 1ml enzyme solution each for 24 hours. 
Thereafter 100µl from each well were examined photometrically. Native pericardium served 
as control. 
2.3 Chemical Vapor Deposition (CVD) by a titanium containing precursor 
Before physical titanization of cardiovascular scaffolds by plasma activated chemical gas 
deposition (PACVD) it is necessary to extract its water completely, which is feasible in a 
vacuum by a slow drying process. PACVD is a coating technology (GfE Nürnberg, 
Germany, patent number EP 0 897 997 A1) where the so called precursor 
(Tetrakisdimethylamidotitan, Ti [N (CH3)2]4) is transferred into the gas phase and brought 
into the reactor by a carrier gas (nitrogen). The precursor or parts of the precursor react with 
the substrate creating a resistant layer. Physical plasma however is able to supply the 
substrate with high energy while the temperature during deposition can kept low. Within 
this non isotherm plasma with solely high electron temperature and room temperature of 
the neutrons and ions the electrons can follow a quickly changing electrical field with 
typical values of a radio frequency (40kHz) low pressure plasma as described elsewhere 
(Grill,1994; Sivaram S.1995 ).Thickness of the titanium containing deposit is depend on 
sputtering time. After PACVD the dehydrated implants came to the same shape in 
physiological saline solution as before titanization.   
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Plasma- Titanium Treatment for Collagen Coating at 35 Co
Removal of free aldehyde
Groups by plasma ernergy
 
Fig. 1. Scheme of Chemical Vapor Deposition (CVD) with the gasiform titanium bounded 
organic molecule as precursor at 35 C0. In a vacuum chamber with energy supply by high 
alternative current,  the precursor is deconstructed and precipitated on the plasma activated 
collagen surface (Plasma Activated Chemical Vapor Deposition, PACVD) and electron pair 
bounded to collagen molecules 
2.4 Examination of the titanium coat 
Deposits composition and binding energy of titanium, carbon, oxygen and nitrogen atoms 
could become analyzed by X-ray Photoelectron Spectroscopy (XPS). X-ray activated atoms 
emit electrons from inner electron layers (photo effect) with a distinct kinetic energy being 
specific for each element. The kinetic energy of the emitted electron diagnoses the element 
and therefore the composition of elements within the titanic layer. The chemical binding in 
which an element is, influences the energy levels of its inner electrons. A more 
electronegative partner binds its electrons tighter on its inner electron layers. That influences 
the kinetic energy on the emitted photoelectrons during X-ray application. These values in 
kinetic energy of the emitted photoelectrons enable to determine the chemical binding 
energy between elements during XPS and so in titanic layers as for oxygen, titanium, 
nitrogen and carbon (Dag, 1997; Moulderm,1995). The limited intrinsic depth for XPS of 
about 1 nm requires a removal of substrate in layers using argon ions. The XPS analysis 
showed a maximal surface atom fraction of 21.1±3 8% titanium atoms within a removal time 
of about 300 seconds, which translates to a titanium thickness of 30 nm. The presence of 
oxygen indicated that titanium had been changed by subsequent oxidation into titanium 
dioxide, with an electron-binding energy for titanium of 463 eV. Two peaks for titanium 
represented titanium bound carbon and titanium bound with oxygen as titanium oxide. 
These analyses show an extremely tight electron binding of the titan precursor fragments to 
collagen. Titanium is non removable bounded to collagen in an extremely thin coating onto 
collagen with a diameter of about 30 nano-meters. 
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Fig. 2. REM of GA- fixed and dehydrated pericardium with a magnification of 5000X (left), 
and with a complete covering of the surface by titanium (right) 
Scanning electron microskopic images of  GA-fixed pericardium show a more filigree net 
like structure (Fig.2 left) which disappears after titanization (Fig.2 right). These morphologic 
changes however do not affect the mechanical stability of the pericardium as already 
investigated (unpublished data). After dehydration and a swelling of the soft collagen, the 
titanium coat may burst into grooves. This uncomplete surface covering may have 
important implications on iC3b deposits and PNM attraction as discussed in the following 
descriptions about the immune response. But nevertheless the decovering of collagene by 
these grooves is manly dependent on the chosen dehydration procedure. 
3. Immunology of glutaraldehyde-fixed bovine pericardium 
Glutaraldehyd-fixed heart valve prostheses  calcify and fail in a time period lesser than 12 
years (Williams et. al.,1982). Some investigators believe that the  GA-process leads to 
calcification and failure of the valves due to chemical processes (Simionescu, 2004). Others  
are convinced the main break down  of GA-fixed valves is caused by an immunologic 
response (Rocchini et. al.,1981; Williams et.al., 1982; Ueyama et.al, 2002; Rizwan et.al.,2006). 
They showed in a young animal model that GA-fixed xenograft valves undergo rejection 
and that inflammation is correlated to calcification (Rizwan et.al., 2006).  
Young patients with a strong immune system  show a valve break down very quickly (<5) 
years (Rocchini et. al.,1981; Williams et.al., 1982; ). In patients > 70 years  with a minor 
immune response bio-prosthetic valves function well > 10 years (Ueyama et.al, 2002).  
Xenogenic organ transplantation arises a very aggressive form of humoral and cellular 
immune rejection with tissue infiltrations by lymphocytes and monocytes (Fischbein et.al., 
2000). Whereas the immunologic lymphocytes and monocytes response could become 
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decreased by de-cellularization or GA-fixation the granulocyte recruitments in de-
cellularized xenografts and GA-fixed heart valves were not influenced at all. The residual 
immuno-stimulatory activity of de-cellularized porcine vascular tissue towards 
polymorphonuclear (PNM) cells resp. granulocyte recruitments, observed in vitro 
(Fischbein et. al., 2000; Juthier et.al; 2006), correlates with in vivo findings with de-
cellularized human and porcine heart valves ( Friedhelm et.al; 2005; Rieder et.al.; 2006; 
Bastian et.al., 2008). For the evaluation of the immunologic activity of GA- fixed pericardium 
in vitro blood sampling, plasma preparation and isolation of PNMs are necessary. 
3.1 Blood sampling, preparation of plasma, and isolation of PMN  
Venous blood was collected from 3 healthy adult volunteers who were not using any 
medications and who gave informed consent (approved by the ethical committee, Medical 
University of Vienna). Whole blood was anti-coagulated with 5 IU/ml heparin and 
centrifuged at 2000 x g for 15 min to obtain plasma. Human PMN were retrieved from 
EDTA-anticoagulated venous blood by lysing 1ml blood with 5ml 0.9% (w/v) ammonium 
chloride for 15 min at 4°C, followed by centrifugation at 160 x g and 4°C for 10 min (Nilsson, 
2001). The supernatant was discarded and the cell pellet washed three times with PBS. Cells 
were subsequently re-suspended in RPMI 1640 medium (BioWhittakerTM, Verbiers, 
Belgium) to a final concentration of 5000/µl and immediately used for the experiments. The 
cell suspensions comprised 84.4±3.1% PMN, 11.6±2.7% lymphocytes, and 3.5±1.6% 
monocytes. The platelet contamination was less than 0.1 platelet per PMN. These 
procedures were necessary for the quantification of IC3b deposits on the blood contacting 
surface of the  GA-fixed pericardium and the granulocyte-matrix adhesion experiments. 
3.2 IC3b- deposits  
IgG deposits(iC3b) were visualized by an immune staining as described elsewhere ( Bastian 
et. al.; 2008) and shown in figure 4. They are documented as coloured pixels (red). Pixels are 
counted electronically.  
IC3b- deposits within  the control group with GA-fixed pericardium were regarded as 100%; in 
the titanized group IC3b deposits were evaluated as 34%. The authors opinion is, that these 
preliminary results can become further optimised (further decrease of immunologic response) 
by an advanced procedure of pericard drying and plasma deposition based on titanium. 
3.3 Granulocyte/matrix adhesion experiments 
Platelets of titanium coated, glutaraldehyde-fixed bovine pericardium were brought into an 
immunologic test setting inducing a complement-mediated granulocyte adhesion and 
activation as described elsewhere ( Bastian et. al.; 2008).  
Plasma used for pre-treating the tissue samples and granulocytes was obtained from the 
same donor during each experiment. Tissue specimens (0.5 x 0.5 cm) were either incubated 
with 20% of heparinized autologous plasma (diluted in PBS containing 0.15 mmol/l Ca2+ 
and 0.5 mmol/l Mg2+) on a rocking platform for 5h each at 37°C, or left untreated. Cryostat 
sections were incubated with 5,000 PMN/µl for 15 minutes in a humidified incubation 
chamber at room temperature (RT). This incubation time was chosen since it proved to be 
optimal for demonstrating PMN adhesion in vitro. 
PMN quantification was performed by counting the leucocytes (including 86% PMNs) near 
the blood contacting surface of the pericard within an areas of 3x3 mm. Five samples from 
each histologic slice were taken for the evaluation of PNMs.   
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Nano- coating with titanium remarkably reduced the early immunologic response to GA 
fixed bovine pericardium in vitro. Thus, the titanium coat is protective against iC3b and 
immune based PMN attraction in contact with human blood.  
 
 
 
 
Fig. 3. PNM count in front of the GA-fixed pericard slices were regarded as 100% (top)  
GA- fixed and titanium coated pericardium however reduced the attraction of PNMs to 
6.0% (bottom) as an expression for an extremely reduced immune response 
4. Endothelialization 
Glutardialdehyde’s toxicity however prevents biological coating. Detoxification of 
glutaraldehyde-fixed scaffolds by amino acids (Fischlein et.al, 1994) and by citric acids 
(Lehner et.al., 1997; Gulbins et.al., 2003) in vitro were successfully applied for partial 
detoxification but endothelialization was only possible by pre-seeding with fibroblasts. Such 
pre-seeded layers on porcine heart valves were stable in a sheep model (Gulbins et.al., 
2003,2006). Due to the fibroblasts however, the valves showed a thickening of the leaflets 
resulting in an impairment of function. 
Recent investigations  developed detoxification strategies and applied nano- technological 
methods such as ultrathin titanium surface coating on glutaraldehyde fixed bovine 
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pericardium as the base material for prosthetic heart valves ( Guldner et.al., 2009). 
Titanization by chemical vapor deposition was feasible at temperatures between 30-35°C 
(Grill et.al., 1994; Silvaram et.al., 1995; Dag,1995). For endothelial cell adhesion on a titanium 
surface endothelial cell cultures were performed. 
 
 
 
 
Fig. 4. Immune staining of iC3b deposits on GA-fixed pericardium (top) was control and 
defined as 100% pixels, titanium coated pericardium platelets showed a count of a decreased 
number of pixels to 34% (bottom) as an expression of an impressive lesser immune response 
as to the uncoated GA-fixed pericardium 
4.1 Cell culture 
Endothelial cells have been isolated from human saphena veins, gained from coronary 
bypass surgery. Ethical approval was obtained from the Ethical Commission on Research on 
Humans of the University of Schleswig Holstein, Campus Lübeck, Germany (registration 
www.intechopen.com
  
Regenerative Medicine and Tissue Engineering - Cells and Biomaterials 
 
470 
No.05-097). Patients had been informed before surgery that parts of their veins were to be 
used for research purposes. The vein pieces were cannulated, rinsed with cell medium then 
filled with 0.5% dispase and incubated for 20 minutes at 37°C and 5% CO2. Then solution 
was then centrifugated at 1200 upm for 5 minutes, the cell pellet was re-suspended in 
endothelial growth medium (EGM-2; Cambrex, Walkersville, US) and plated on cell culture 
flasks. For passaging, endothelial cells were trypsinized after reaching confluence, 
centrifuged at 1200 upm for 5 minutes, then re-suspended in endothelial cell medium and 
plated out again. Cell counting has been performed by incubating 20µl of the cell suspension 
with an equal amount of trypan-blue and then counting using a Neubauer chamber. 
Pre-treated platelets of glutardialdehyde fixed pericardium were examined by scanning 
electron microscopy (SEM) after 48 hours of incubation with human endothelial cells. SEM 
showed malformed non confluent endothelial cells on Citric Acid (10%) only treated 
pericardium (Figure 5a, n=5). In contrast to that, a completely confluent cell layer of regular 
human endothelial cells could be observed on pericardial surfaces treated with a 
combination of Citric Acid (10%) and plasma-titan method (n=5) (Figure 5).Toxicity of 
pericardium was reduced by combination of procedures using ALDH and plasma-titanium 
coating (n=12) to 17.3± 2.1% (p≤0.01). 
 
 
Fig. 5. Scanning electron microscopy of human endothelial cells on glutardialdehyde fixed 
bovine pericardium shows sporatic cell cadavers (a), treated with citric acid (10%) 
demonstrates malformed endothelial cells (b) detoxified with citric acid (10%) and ALDH 
results in non confluent endothelial layers (c)  the nano-technological promoted procedure 
with a detoxification and a titan plasma administration enabled a confluent layer of 
endothelial cells (d) 
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Several platelets of pericardium differently detoxified were examined by scanning electron 
microscopy (SEM) after being seeded in vitro with human endothelial cells. Of each 
specimen, 10 visual fields were evaluated under 1000x magnification. Both cell morphology 
and confluence of the cell layer were assessed semi-quantitatively by different examiners.  
4.2 Cell adhesion under flow conditions 
A flow chamber made of V4A steel and glass was able to incorporate in its bottom six 
detoxified and endothelialized platelets within V4A steel rings.. It was constructed such, 
that no significant turbulences happened and that the laminar shear stress of 30 dyn/cm2 
and flow of 5 L/min was similar to the intra-aortic fluid dynamic. 
Adhesion of human endothelial cells on glutaraldehyde fixed pericardial platelets treated by 
CA 10%, ALDH and a titanium coating was expressed by the vitality of the remaining cells 
after a flow of 5L/min for 24 hours within a flow chamber. 
Vitality of the endothelial cells was measured by the extinction of the MTS-test of 72% (n=6) 
after a pre-seeding of 15 min and 81% (n=6) after pre-seeding of 60 min (Fig.6). 
 
 
Fig. 6. Extinction of MTS-test for titanium treated (n=6) endothelialized glutaraldehyde-
fixed bovine pericardium platelets after  in a flow channel of 5L/min. Adhesion of human 
endothelial cells is 72% after a pre-seeding of 15 min and 81% after pre-seeding of 60 min 
This study provides evidence that titanium coating in combination with a CA10% and 
ALDH treatment removed most of the free aldehyde ligands of glutardialdehyde fixed 
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pericardium in-vitro and enabled a living and confluent cell layer of human endothelial cells 
with a high adhesion capacity. This study gave evidence that  titanium coating applied to a 
porcine heart valve  may enable a self-seeding with cells within circulation. 
4.3 The first self-endothelialized titanium coated glutaraldehyde-fixed heart halve 
prosthesis within systemic circulation 
Implantation of a pre-seeded aortic valve in the aorta descendens position in a sheep model 
without extra-corporal circulation was already described before (Gulbins et.al., 2006). We 
used a male Bore goat with a weight of 83 kilograms (ethical accreditation of the Ethics 
Committees for Animals in Kiel, V 362-72241.122-6) to create a muscular blood pump in 
aorta descendens position (Fig.7a). We integrated two glutaraldehyde-fixed, titanium coated 
and detoxified porcine heart valves into the inflow and outflow part of the pumping 
chamber of this muscular blood pump, the Biomechanical Heart (Guldner et.al., 2001). This 
skeletal muscle ventricle pumped with a frequency of 20 beats per minute. After 6 months of 
pumping the valves were removed from the pumping chamber for histological analysis.  
Valve leaflets from the two valves were imbedded in paraffin, cut into sections of 4 µm and 
treated with a hematoxilin-eosin staining . Other sections were treated using polyclonal 
antibodies against factor VIII (Dako, Hamburg, Germany). After incubation with primary 
antibody, an anti-rabbit IgG antibody was applied which was conjugated with alkaline 
phosphatase (SIGMA,Steinheim, Germany). Photographic documentation was performed 
by using a magnification of 20X. 
 
 
Fig. 7a. Valve’s topography within the inflow and outflow part of the pumping chamber of a 
Biomechanical Heart, a muscular blood pump within aorto -aortic position 
Porcine titanized and detoxified aortic valves, having been implanted heterotopic within the 
systemic circulation of a goat for 6 months, were macroscopically well and showed a normal 
opening and closure behaviour. Cross-section of a valve leaflet demonstrated a cell-seeding 
of its blood contacting surface (HE-staining magnification 20X). Immunhistochemic staining 
against factor VIII proved a complete endothelialization of the total blood contacting surface, 
labelled with alkaline phosphatase and visualized with immunefluorescense (7b, bottom). 
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Fig. 7b. Porcine detoxified and titanized aortic valve, having been implanted heterotopic 
within the aorta of a goat for 6 months (top). Immunhistochemic staining against factor VIII 
(bottom) proves a complete endothelialization over the total blood contacting surface 
(bottom) 
5. Conclusions 
Tissue engineering of heart valves is considered to be a hopeful concept to generate 
improved substitute bioprostheses. However, because there is yet no realizable blueprint to 
construct semilunar valves (Sievers, 2007) our aim was to refine conventional, proven 
bioprostheses using chemical agents as citric acid and aldehyde dehydrogenase (ALDH) for 
detoxification and innovative nanotechnologies such as plasma deposition with the most 
biocompatible titanium coating. These procedures have shown to reduce the immune 
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response to the glutardialdehyde-based cross-linked collagen, probably the main reason 
why GA- fixed bioprostheses calcify and fail and enable the valve-protecting endo-
thelialization in vitro under static and flow conditions..  
Furthermore this new method combining biochemical methods of detoxification with 
nanotechnology including a titanium coating created the first self-seeded glutaraldehyde-
fixed biologic heart valve within circulation under arterial pressure. This technology might 
open a new field of research for developing new heart valves with improved durability and 
function. In future big animal studies are necessary to approve this procedure mainly to 
increase durability and function in biologic glutaraldahyde fixed heart valves over several 
decades and avoid re-operations caused by valve degeneration 
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